Beschreibung
Mesenchymal stem cells (MSCs) are characterized by high angiogenic power, and are understood to be beneficial against endothelial dysfunction. This study investigates the impact of the transplantation of allogeneic MSCs from adult bone marrow on microvascular rarefaction, endothelial dysfunction, and hypertension in rats. Results suggest that MSCs present a promising treatment strategy against hypertension. The mechanism appears to not involve changes of microvascular circulation.
Autorenporträt
Prof Dr. Loss holds a PhD (2012) in Clinical Pathology (Pathophysiology of hypertension) from the Universidade Federal do Triangulo Mineiro-UFTM, in Brazil. He completed postdoctoral research on heart rate variability at the University of Milan, in Italy, and currently is an Adjunct Professor and researcher at the UFTM, Brazil.
Herstellerkennzeichnung:
OmniScriptum SRL
Str. Armeneasca 28/1, office 1
2012 Chisinau
MD
E-Mail: info@omniscriptum.com
